Samuel D Saibil

5PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 11, 2025
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.

Vincent Rondeau, Suraj Bansal, Marco M Buttigieg

|Aug 13, 2025
Prognostic and Predictive Value of ctDNA for Metastatic Uveal Melanoma: A Systematic Review and Meta-Analysis.

Mariana Macambira Noronha, Luís Felipe Leite da Silva, Luiz Felipe Costa Almeida

|Jan 23, 2020
IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function.

Michael St Paul, Samuel D Saibil, Scott C Lien

|Dec 22, 2018
Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy.

Samuel D Saibil, Michael St Paul, Robert C Laister

|Nov 08, 2017
Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.

Charles W Tran, Samuel D Saibil, Thierry Le Bihan

Pageof 1

Frequent Collaborators

3 joint publications

Pamela S Ohashi

2 joint publications

Mauricio Ribeiro

1 joint publications

Charles W Tran

1 joint publications

Thierry Le Bihan